Off-Label Concerns With InFuse Raised, But Panel Decides Against Bundling
This article was originally published in The Gray Sheet
Executive Summary
Medtronic/Sofamor Danek successfully avoided a proposed condition that would have bundled its LT-Cage lumbar tapered fusion device with its InFuse bone graft during FDA's Orthopedic & Rehabilitation Devices Panel review Jan. 10